Catherine Zheng, Amanda Mather, Sarah Roxburgh, Brendon L. Neuen, Jeffrey T. Ha
The management of diabetic kidney disease secondary to type 2 diabetes now centres on four ‘pillars’ of treatment, in addition to lifestyle modification. Early implementation of these therapies can have a significant impact on long-term outcomes for patients with this condition.
Only a third of patients with depression achieve remission with first-line selective serotonin reuptake inhibitors (SSRIs). What should be done when patients with depression either fail to respond to, or do not tolerate, SSRIs and serotonin-noradrenaline reuptake inhibitors?
Obesity management is an important priority to reduce the burden of incident and recurrent cardiovascular events. Lifestyle management remains a cornerstone of management; however, the pharmacological treatment landscape is rapidly evolving with recent trials demonstrating the benefit of glucagon-like peptide-1 receptor agonists in inducing weight loss and reducing cardiovascular events.
The 0.5% 5-fluorouracil and 10% salicylic acid solution is a valuable addition to the range of treatment options for actinic keratoses, offering a combined topical approach that may improve efficacy and patient adherence.
How should this 5-month-old boy who presents in general practice with two days of fever, cough and runny nose be assessed and what are the next steps in management?
